Opicinumab: is it a potential treatment for multiple sclerosis?

Ann Transl Med. 2020 Jul;8(14):892. doi: 10.21037/atm.2020.03.131.

Authors

Zubair Ahmed¹, Daniel Fulton¹, Michael R Douglas^{1

2

3}

Affiliations

¹ Neuroscience & Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
² School of Life and Health Sciences, Aston University, Birmingham, UK.
³ Department of Neurology, Dudley Group NHS Foundation Trust, Dudley, UK.

No abstract available

Publication types

Editorial
Comment